US › Healthcare

Im Cannabis Corp (IMCC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.64+7.52%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$7.6M

Revenue YoY

-40.2%

Net profit

$-4.4M

EPS

$-0.34

Net margin

-57.5%

Key statistics

Market cap

$977,622

Forward P/E

42.4

P/B

3.98

Book value

$-7.26

EPS (TTM)

$-59.01

52-week high

$62.40

52-week low

$0.58

50-day MA

$1.96

200-day MA

$10.57

Beta

2.55

Analyst view

with an average price target of $8.22.

Shareholding

Insiders

34.40%

Institutions

0.70%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	3.74%
Jane Street Group LLC	0.64%
StoneX Group Inc	0.39%
Bank of Montreal	0.21%
BMO Capital Markets Corp.	0.21%
Federation des caisses Desjardins du Quebec	0.03%
NATIONAL BANK OF CANADA /FI/	0.00%
Royal Bank of Canada	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Im Cannabis Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.